Join
Live feed
·
INSIDERFilingvia Quantisnow
Nurix Therapeutics Inc. logo

Chief Financial Officer Van Houte Hans sold $233,319 worth of shares (14,055 units at $16.60) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 37,592 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NRIX· Nurix Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NRIX (Nurix Therapeutics Inc.) and more on Quantisnow.